RxDoctor Payments Data

Brittany Smirnov, DO

Procedural Dermatology · Falls Church, VANPI 1295129294

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (40.0%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 31 manufacturers reported payments, led by Arcutis Biotherapeutics, Inc. at 30.8% of the total. 2025 is the largest year on record at $17,970, more than ten times the $387 reported in 2019.

$26,658in general payments, 2019–2025

Across 370 payments — averaging $72.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arcutis Biotherapeutics, Inc.$8K
  • Kowa Pharmaceuticals America, Inc.$7K
  • Regeneron Healthcare Solutions, Inc.$4K
  • AbbVie$1K
  • Johnson & Johnson$1K
  • Sanofi$816
  • plus $4K from 25 others

What the payments were for

  • Consulting fees$10,65340%
  • Speaking & faculty fees$6,17523%
  • Travel & lodging$9894%
  • Food & beverage$8,67733%
  • Education$1641%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few procedural dermatology providers in Virginiato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$226,289
Medicare patients
687
Services billed
3,508

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab14$191,646
Fluocinonide64$3,332
Clobetasol Propionate30$3,132
Naftifine Hcl13$2,714
Tretinoin20$1,442
Metronidazole16$1,157
Triamcinolone Acetonide70$710
Clindamycin Phosphate20$676
Mupirocin41$620
Ketoconazole42$556
CiclopiroxCiclopirox Olamine22$489
Doxycycline Hyclate23$282
ValacyclovirValacyclovir Hcl21$272
Minoxidil19$167
Doxycycline Monohydrate11$134

Paid to pharmacies, not to this prescriber.

Other procedural dermatology in Falls Church

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →